A single-center observational cohort (n=116; 81% RRMS) receiving ocrelizumab from 2018–2023 enabled longitudinal tracking of IgG, IgA, and IgM across treatment cycles. Serial dosing produced gradual ...

House lawmakers reviewed veterans' health bills focused on mental health, rural access, spinal injury care, and military aviation research. Today, the House Committee on Veterans Affairs subcommittee ...

Legislation delays mandatory digital-only quality reporting for Shared Savings Program ACOs, addressing gaps in EHR/IT infrastructure that disproportionately affect smaller, rural, and independent ...

In this episode, 'Screening, Risk Stratification, and the Multidisciplinary Care Model for MASH,' the hepatologist Nadege Gunn, MD explores the following questions: 1. How would you characterize the ...

CDC ended the federal response June 24, 2026, after risk diminished, releasing >100 deployed staff from the peak incident ...

COA’s AI Playbook provides a structured, practice-oriented framework to prioritize AI use cases, align stakeholders, and ...

A $5,000 annual out-of-pocket cap would add catastrophic financial protection to traditional Medicare, harmonizing benefit design with Medicare Advantage and most private insurance coverage.

AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...

Retrospective single-center review of 80 HFrEF patients added SGLT2 inhibitors on stable guideline-directed therapy, with ...

As discussed at a recent IVBM event, Robert Kratzke, MD, outlines essential biomarkers, NGS panel selection, and next steps ...

Indications now include pediatric plaque psoriasis and active PsA starting at age 6, positioning risankizumab as the first US-approved IL-23(p19) inhibitor for <40 kg pediatric patients. Weight-tiered ...

Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...